Hwail Pharm화일약품
061250 · KOSDAQ · ₩061250 · 화일약품
₩5,750▼ ₩40 (0.69%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 7.6% | 6.6% | 8.8% | 9.4% | 10.3% | 9.9% |
| Operating margin | −2.9% | −2.3% | 0.6% | 1.7% | 3.6% | 4.0% |
| Net margin | 4.6% | −0.2% | 5.4% | 3.2% | −4.8% | 2.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −10.0% | −15.8% | −2.3% | −7.2% | +23.4% | — |
| Operating income growth | −14.4% | −401.9% | −63.1% | −57.1% | +11.9% | — |
| Net income growth | +1,889.1% | −103.6% | +67.8% | +161.1% | −322.6% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 2.0% | −0.1% | 3.4% | 2.2% | −3.5% | 1.6% |
| Return on assets | 1.7% | −0.1% | 3.2% | 2.1% | −3.3% | 1.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 4.0% | 3.0% | 6.0% | 6.6% | 5.7% | 6.9% |
| Net debt to equity | — | −38.7% | −24.5% | −40.0% | −24.5% | −18.2% |
| Current ratio | 1,707.4% | 2,173.6% | 1,142.2% | 1,239.2% | 1,738.7% | 1,233.0% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Hwail Pharm / 화일약품 / 061250 / KRX:061250
Source: KRX statistical information